China Molecular Diagnostics (MDx) Point of Care Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Molecular Diagnostics (MDx) Point of Care industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Roche Diagnostics

    • Hologic Inc

    • Trinity Biotech

    • DxNA LLC

    • Johnson & Johnson

    • F Hoffmann-La Roche AG

    • Siemens Healthineers

    • QIAGEN NV

    • Becton Dickinson & Company

    • Mesa Biotech Inc

    • Luminex Corporation

    • Quidel Corporation

    • EKF Diagnostics

    By Type:

    • Polymerase Chain Reaction (PCR)

    • Isothermal Nucleic Acid Amplification Technology (INAAT)

    • Digital PCR

    • Others

    • Real Time PCR

    By Application:

    • Prenatal Testing

    • Hematology

    • Others

    • Infectious Diseases

    • Oncology

    • Endocrinology

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Molecular Diagnostics (MDx) Point of Care Market Overview 2018-2029

    • 1.1 China Molecular Diagnostics (MDx) Point of Care Industry Development Overview

    • 1.2 China Molecular Diagnostics (MDx) Point of Care Industry Development History

    • 1.3 China Molecular Diagnostics (MDx) Point of Care Industry Market Size (2018-2029)

    • 1.4 China Molecular Diagnostics (MDx) Point of Care Market Analysis by Type from Production Side

      • 1.4.1 China Molecular Diagnostics (MDx) Point of Care Production Volume, Production Value and Growth Rate of Polymerase Chain Reaction (PCR) (2018-2029)

      • 1.4.2 China Molecular Diagnostics (MDx) Point of Care Production Volume, Production Value and Growth Rate of Isothermal Nucleic Acid Amplification Technology (INAAT) (2018-2029)

      • 1.4.3 China Molecular Diagnostics (MDx) Point of Care Production Volume, Production Value and Growth Rate of Digital PCR (2018-2029)

      • 1.4.4 China Molecular Diagnostics (MDx) Point of Care Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.5 China Molecular Diagnostics (MDx) Point of Care Production Volume, Production Value and Growth Rate of Real Time PCR (2018-2029)

    • 1.5 China Molecular Diagnostics (MDx) Point of Care Market Analysis by Application from Consumption End

      • 1.5.1 China Molecular Diagnostics (MDx) Point of Care Sales Volume, Sales Value and Growth Rate of Prenatal Testing (2018-2029)

      • 1.5.2 China Molecular Diagnostics (MDx) Point of Care Sales Volume, Sales Value and Growth Rate of Hematology (2018-2029)

      • 1.5.3 China Molecular Diagnostics (MDx) Point of Care Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.4 China Molecular Diagnostics (MDx) Point of Care Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)

      • 1.5.5 China Molecular Diagnostics (MDx) Point of Care Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

      • 1.5.6 China Molecular Diagnostics (MDx) Point of Care Sales Volume, Sales Value and Growth Rate of Endocrinology (2018-2029)

    • 1.6 China Molecular Diagnostics (MDx) Point of Care Market Analysis by Region

      • 1.6.1 North China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate from 2018-2029

    Chapter 2 China Molecular Diagnostics (MDx) Point of Care Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Molecular Diagnostics (MDx) Point of Care Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Molecular Diagnostics (MDx) Point of Care Market Status and Competition Analysis in 2023

      • 2.2.3 China Molecular Diagnostics (MDx) Point of Care Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Molecular Diagnostics (MDx) Point of Care Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Molecular Diagnostics (MDx) Point of Care Industry Development

    Chapter 3 Molecular Diagnostics (MDx) Point of CareIndustry Chain Analysis

    • 3.1 Molecular Diagnostics (MDx) Point of Care Industry Chain

    • 3.2 Molecular Diagnostics (MDx) Point of Care Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Molecular Diagnostics (MDx) Point of Care Market

    • 3.3 Molecular Diagnostics (MDx) Point of Care Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Molecular Diagnostics (MDx) Point of Care Market

    Chapter 4 China Molecular Diagnostics (MDx) Point of Care Market, by Type

    • 4.1 China Molecular Diagnostics (MDx) Point of Care Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Molecular Diagnostics (MDx) Point of Care Total Production Volume and Growth Rate from Production Side

    • 4.5 China Molecular Diagnostics (MDx) Point of Care Production Volume and Growth Rate, by Type

      • 4.5.1 China Molecular Diagnostics (MDx) Point of Care Production Volume and Growth Rate of Polymerase Chain Reaction (PCR)

      • 4.5.2 China Molecular Diagnostics (MDx) Point of Care Production Volume and Growth Rate of Isothermal Nucleic Acid Amplification Technology (INAAT)

      • 4.5.3 China Molecular Diagnostics (MDx) Point of Care Production Volume and Growth Rate of Digital PCR

      • 4.5.4 China Molecular Diagnostics (MDx) Point of Care Production Volume and Growth Rate of Others

      • 4.5.5 China Molecular Diagnostics (MDx) Point of Care Production Volume and Growth Rate of Real Time PCR

    Chapter 5 China Molecular Diagnostics (MDx) Point of Care Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Molecular Diagnostics (MDx) Point of Care Total Market Size and Growth Rate from Consumption End

    • 5.5 China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate, by Application

      • 5.5.1 China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate of Prenatal Testing

      • 5.5.2 China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate of Hematology

      • 5.5.3 China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate of Others

      • 5.5.4 China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate of Infectious Diseases

      • 5.5.5 China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate of Oncology

      • 5.5.6 China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate of Endocrinology

    Chapter 6 China Molecular Diagnostics (MDx) Point of Care Market, by Region

    • 6.1 China Molecular Diagnostics (MDx) Point of Care Production Volume and Production Value, by Region

    • 6.2 China Molecular Diagnostics (MDx) Point of Care Sales Volume and Sales Value, by Region

    Chapter 7 North China Molecular Diagnostics (MDx) Point of Care Market Analysis

    • 7.1 North China Molecular Diagnostics (MDx) Point of Care Market, by Type

    • 7.2 North China Molecular Diagnostics (MDx) Point of Care Market, by Application

    Chapter 8 Central China Molecular Diagnostics (MDx) Point of Care Market Analysis

    • 8.1 Central China Molecular Diagnostics (MDx) Point of Care Market, by Type

    • 8.2 Central China Molecular Diagnostics (MDx) Point of Care Market, by Application

    Chapter 9 South China Molecular Diagnostics (MDx) Point of Care Market Analysis

    • 9.1 South China Molecular Diagnostics (MDx) Point of Care Market, by Type

    • 9.2 South China Molecular Diagnostics (MDx) Point of Care Market, by Application

    Chapter 10 East China Molecular Diagnostics (MDx) Point of Care Market Analysis

    • 10.1 East China Molecular Diagnostics (MDx) Point of Care Market, by Type

    • 10.2 East China Molecular Diagnostics (MDx) Point of Care Market, by Application

    Chapter 11 Northeast China Molecular Diagnostics (MDx) Point of Care Market Analysis

    • 11.1 Northeast China Molecular Diagnostics (MDx) Point of Care Market, by Type

    • 11.2 Northeast China Molecular Diagnostics (MDx) Point of Care Market, by Application

    Chapter 12 Southwest China Molecular Diagnostics (MDx) Point of Care Market Analysis

    • 12.1 Southwest China Molecular Diagnostics (MDx) Point of Care Market, by Type

    • 12.2 Southwest China Molecular Diagnostics (MDx) Point of Care Market, by Application

    Chapter 13 Northwest China Molecular Diagnostics (MDx) Point of Care Market Analysis

    • 13.1 Northwest China Molecular Diagnostics (MDx) Point of Care Market, by Type

    • 13.2 Northwest China Molecular Diagnostics (MDx) Point of Care Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Roche Diagnostics

        • 14.1.1 Roche Diagnostics Company Profile

        • 14.1.2 Roche Diagnostics Molecular Diagnostics (MDx) Point of Care Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Hologic Inc

        • 14.2.1 Hologic Inc Company Profile

        • 14.2.2 Hologic Inc Molecular Diagnostics (MDx) Point of Care Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Trinity Biotech

        • 14.3.1 Trinity Biotech Company Profile

        • 14.3.2 Trinity Biotech Molecular Diagnostics (MDx) Point of Care Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 DxNA LLC

        • 14.4.1 DxNA LLC Company Profile

        • 14.4.2 DxNA LLC Molecular Diagnostics (MDx) Point of Care Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Johnson & Johnson

        • 14.5.1 Johnson & Johnson Company Profile

        • 14.5.2 Johnson & Johnson Molecular Diagnostics (MDx) Point of Care Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 F Hoffmann-La Roche AG

        • 14.6.1 F Hoffmann-La Roche AG Company Profile

        • 14.6.2 F Hoffmann-La Roche AG Molecular Diagnostics (MDx) Point of Care Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Siemens Healthineers

        • 14.7.1 Siemens Healthineers Company Profile

        • 14.7.2 Siemens Healthineers Molecular Diagnostics (MDx) Point of Care Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 QIAGEN NV

        • 14.8.1 QIAGEN NV Company Profile

        • 14.8.2 QIAGEN NV Molecular Diagnostics (MDx) Point of Care Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Becton Dickinson & Company

        • 14.9.1 Becton Dickinson & Company Company Profile

        • 14.9.2 Becton Dickinson & Company Molecular Diagnostics (MDx) Point of Care Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Mesa Biotech Inc

        • 14.10.1 Mesa Biotech Inc Company Profile

        • 14.10.2 Mesa Biotech Inc Molecular Diagnostics (MDx) Point of Care Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Luminex Corporation

        • 14.11.1 Luminex Corporation Company Profile

        • 14.11.2 Luminex Corporation Molecular Diagnostics (MDx) Point of Care Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Quidel Corporation

        • 14.12.1 Quidel Corporation Company Profile

        • 14.12.2 Quidel Corporation Molecular Diagnostics (MDx) Point of Care Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 EKF Diagnostics

        • 14.13.1 EKF Diagnostics Company Profile

        • 14.13.2 EKF Diagnostics Molecular Diagnostics (MDx) Point of Care Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Molecular Diagnostics (MDx) Point of Care Industry Research Conclusions

    • 15.2 Molecular Diagnostics (MDx) Point of Care Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Molecular Diagnostics (MDx) Point of Care Industry Market Size (2018-2029)

    • Figure China Molecular Diagnostics (MDx) Point of Care Production Volume, Production Value and Growth Rate of Polymerase Chain Reaction (PCR) (2018-2029)

    • Figure China Molecular Diagnostics (MDx) Point of Care Production Volume, Production Value and Growth Rate of Isothermal Nucleic Acid Amplification Technology (INAAT) (2018-2029)

    • Figure China Molecular Diagnostics (MDx) Point of Care Production Volume, Production Value and Growth Rate of Digital PCR (2018-2029)

    • Figure China Molecular Diagnostics (MDx) Point of Care Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Molecular Diagnostics (MDx) Point of Care Production Volume, Production Value and Growth Rate of Real Time PCR (2018-2029)

    • Figure China Molecular Diagnostics (MDx) Point of Care Sales Volume, Sales Value and Growth Rate of Prenatal Testing (2018-2029)

    • Figure China Molecular Diagnostics (MDx) Point of Care Sales Volume, Sales Value and Growth Rate of Hematology (2018-2029)

    • Figure China Molecular Diagnostics (MDx) Point of Care Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Molecular Diagnostics (MDx) Point of Care Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)

    • Figure China Molecular Diagnostics (MDx) Point of Care Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure China Molecular Diagnostics (MDx) Point of Care Sales Volume, Sales Value and Growth Rate of Endocrinology (2018-2029)

    • Figure North China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate from 2018-2029

    • Figure Central China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate from 2018-2029

    • Figure South China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate from 2018-2029

    • Figure East China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate from 2018-2029

    • Figure Molecular Diagnostics (MDx) Point of Care Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Molecular Diagnostics (MDx) Point of Care Market Share by Type in 2018

    • Figure China Molecular Diagnostics (MDx) Point of Care Market Share by Type in 2023

    • Figure China Molecular Diagnostics (MDx) Point of Care Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Molecular Diagnostics (MDx) Point of Care Production Volume and Growth Rate of Polymerase Chain Reaction (PCR) (2018-2023)

    • Figure China Molecular Diagnostics (MDx) Point of Care Production Volume and Growth Rate of Isothermal Nucleic Acid Amplification Technology (INAAT) (2018-2023)

    • Figure China Molecular Diagnostics (MDx) Point of Care Production Volume and Growth Rate of Digital PCR (2018-2023)

    • Figure China Molecular Diagnostics (MDx) Point of Care Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Molecular Diagnostics (MDx) Point of Care Production Volume and Growth Rate of Real Time PCR (2018-2023)

    • Figure China Molecular Diagnostics (MDx) Point of Care Market Share by Application in 2018

    • Figure China Molecular Diagnostics (MDx) Point of Care Market Share by Application in 2023

    • Figure China Molecular Diagnostics (MDx) Point of Care Total Market Size and Growth Rate from Consumption End

    • Figure China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate of Prenatal Testing (2018-2023)

    • Figure China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate of Hematology (2018-2023)

    • Figure China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate of Others (2018-2023)

    • Figure China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate of Infectious Diseases (2018-2023)

    • Figure China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate of Oncology (2018-2023)

    • Figure China Molecular Diagnostics (MDx) Point of Care Market Size and Growth Rate of Endocrinology (2018-2023)

    • Table China Molecular Diagnostics (MDx) Point of Care Production Volume by Region (2018-2023)

    • Table China Molecular Diagnostics (MDx) Point of Care Production Volume Share by Region (2018-2023)

    • Figure China Molecular Diagnostics (MDx) Point of Care Production Volume Share by Region (2018-2023)

    • Table China Molecular Diagnostics (MDx) Point of Care Production Value by Region (2018-2023)

    • Table China Molecular Diagnostics (MDx) Point of Care Production Value Share by Region (2018-2023)

    • Figure China Molecular Diagnostics (MDx) Point of Care Production Value Share by Region (2018-2023)

    • Table China Molecular Diagnostics (MDx) Point of Care Sales Volume by Region (2018-2023)

    • Table China Molecular Diagnostics (MDx) Point of Care Sales Volume Share by Region (2018-2023)

    • Figure China Molecular Diagnostics (MDx) Point of Care Sales Volume Share by Region (2018-2023)

    • Table China Molecular Diagnostics (MDx) Point of Care Sales Value by Region (2018-2023)

    • Table China Molecular Diagnostics (MDx) Point of Care Sales Value Share by Region (2018-2023)

    • Figure China Molecular Diagnostics (MDx) Point of Care Sales Value Share by Region (2018-2023)

    • Table North China Molecular Diagnostics (MDx) Point of Care Production Volume by Type (2018-2023)

    • Table North China Molecular Diagnostics (MDx) Point of Care Production Volume Share by Type (2018-2023)

    • Figure North China Molecular Diagnostics (MDx) Point of Care Production Volume Share by Type (2018-2023)

    • Table North China Molecular Diagnostics (MDx) Point of Care Sales Volume by Application (2018-2023)

    • Table North China Molecular Diagnostics (MDx) Point of Care Sales Volume Share by Application (2018-2023)

    • Figure North China Molecular Diagnostics (MDx) Point of Care Sales Volume Share by Application (2018-2023)

    • Table Central China Molecular Diagnostics (MDx) Point of Care Production Volume by Type (2018-2023)

    • Table Central China Molecular Diagnostics (MDx) Point of Care Production Volume Share by Type (2018-2023)

    • Figure Central China Molecular Diagnostics (MDx) Point of Care Production Volume Share by Type (2018-2023)

    • Table Central China Molecular Diagnostics (MDx) Point of Care Sales Volume by Application (2018-2023)

    • Table Central China Molecular Diagnostics (MDx) Point of Care Sales Volume Share by Application (2018-2023)

    • Figure Central China Molecular Diagnostics (MDx) Point of Care Sales Volume Share by Application (2018-2023)

    • Table South China Molecular Diagnostics (MDx) Point of Care Production Volume by Type (2018-2023)

    • Table South China Molecular Diagnostics (MDx) Point of Care Production Volume Share by Type (2018-2023)

    • Figure South China Molecular Diagnostics (MDx) Point of Care Production Volume Share by Type (2018-2023)

    • Table South China Molecular Diagnostics (MDx) Point of Care Sales Volume by Application (2018-2023)

    • Table South China Molecular Diagnostics (MDx) Point of Care Sales Volume Share by Application (2018-2023)

    • Figure South China Molecular Diagnostics (MDx) Point of Care Sales Volume Share by Application (2018-2023)

    • Table East China Molecular Diagnostics (MDx) Point of Care Production Volume by Type (2018-2023)

    • Table East China Molecular Diagnostics (MDx) Point of Care Production Volume Share by Type (2018-2023)

    • Figure East China Molecular Diagnostics (MDx) Point of Care Production Volume Share by Type (2018-2023)

    • Table East China Molecular Diagnostics (MDx) Point of Care Sales Volume by Application (2018-2023)

    • Table East China Molecular Diagnostics (MDx) Point of Care Sales Volume Share by Application (2018-2023)

    • Figure East China Molecular Diagnostics (MDx) Point of Care Sales Volume Share by Application (2018-2023)

    • Table Northeast China Molecular Diagnostics (MDx) Point of Care Production Volume by Type (2018-2023)

    • Table Northeast China Molecular Diagnostics (MDx) Point of Care Production Volume Share by Type (2018-2023)

    • Figure Northeast China Molecular Diagnostics (MDx) Point of Care Production Volume Share by Type (2018-2023)

    • Table Northeast China Molecular Diagnostics (MDx) Point of Care Sales Volume by Application (2018-2023)

    • Table Northeast China Molecular Diagnostics (MDx) Point of Care Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Molecular Diagnostics (MDx) Point of Care Sales Volume Share by Application (2018-2023)

    • Table Southwest China Molecular Diagnostics (MDx) Point of Care Production Volume by Type (2018-2023)

    • Table Southwest China Molecular Diagnostics (MDx) Point of Care Production Volume Share by Type (2018-2023)

    • Figure Southwest China Molecular Diagnostics (MDx) Point of Care Production Volume Share by Type (2018-2023)

    • Table Southwest China Molecular Diagnostics (MDx) Point of Care Sales Volume by Application (2018-2023)

    • Table Southwest China Molecular Diagnostics (MDx) Point of Care Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Molecular Diagnostics (MDx) Point of Care Sales Volume Share by Application (2018-2023)

    • Table Northwest China Molecular Diagnostics (MDx) Point of Care Production Volume by Type (2018-2023)

    • Table Northwest China Molecular Diagnostics (MDx) Point of Care Production Volume Share by Type (2018-2023)

    • Figure Northwest China Molecular Diagnostics (MDx) Point of Care Production Volume Share by Type (2018-2023)

    • Table Northwest China Molecular Diagnostics (MDx) Point of Care Sales Volume by Application (2018-2023)

    • Table Northwest China Molecular Diagnostics (MDx) Point of Care Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Molecular Diagnostics (MDx) Point of Care Sales Volume Share by Application (2018-2023)

    • Table Roche Diagnostics Company Profile

    • Table Roche Diagnostics Molecular Diagnostics (MDx) Point of Care Revenue, Price and Gross (2018-2023)

    • Table Hologic Inc Company Profile

    • Table Hologic Inc Molecular Diagnostics (MDx) Point of Care Revenue, Price and Gross (2018-2023)

    • Table Trinity Biotech Company Profile

    • Table Trinity Biotech Molecular Diagnostics (MDx) Point of Care Revenue, Price and Gross (2018-2023)

    • Table DxNA LLC Company Profile

    • Table DxNA LLC Molecular Diagnostics (MDx) Point of Care Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Molecular Diagnostics (MDx) Point of Care Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche AG Company Profile

    • Table F Hoffmann-La Roche AG Molecular Diagnostics (MDx) Point of Care Revenue, Price and Gross (2018-2023)

    • Table Siemens Healthineers Company Profile

    • Table Siemens Healthineers Molecular Diagnostics (MDx) Point of Care Revenue, Price and Gross (2018-2023)

    • Table QIAGEN NV Company Profile

    • Table QIAGEN NV Molecular Diagnostics (MDx) Point of Care Revenue, Price and Gross (2018-2023)

    • Table Becton Dickinson & Company Company Profile

    • Table Becton Dickinson & Company Molecular Diagnostics (MDx) Point of Care Revenue, Price and Gross (2018-2023)

    • Table Mesa Biotech Inc Company Profile

    • Table Mesa Biotech Inc Molecular Diagnostics (MDx) Point of Care Revenue, Price and Gross (2018-2023)

    • Table Luminex Corporation Company Profile

    • Table Luminex Corporation Molecular Diagnostics (MDx) Point of Care Revenue, Price and Gross (2018-2023)

    • Table Quidel Corporation Company Profile

    • Table Quidel Corporation Molecular Diagnostics (MDx) Point of Care Revenue, Price and Gross (2018-2023)

    • Table EKF Diagnostics Company Profile

    • Table EKF Diagnostics Molecular Diagnostics (MDx) Point of Care Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.